Manhattan Associates (MANH) EBITDA (2010 - 2026)

Manhattan Associates (MANH) has 17 years of EBITDA data on file, last reported at $64.9 million in Q1 2026.

• Quarterly EBITDA rose 2.79% year-over-year to $64.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $281.6 million (up 5.4% YoY) and the FY2025 annual result came in at $279.8 million, up 6.96% from the prior year.
• EBITDA eased to $64.9 million in Q1 2026 per MANH's latest filing, from $67.0 million in the prior quarter.
• Across five years, EBITDA topped out at $75.8 million in Q3 2025 and bottomed at $34.0 million in Q1 2022.
• The 5-year median for EBITDA is $58.9 million (2023), against an average of $57.0 million.
• Peak annual rise in EBITDA reached 64.7% in 2022, while the deepest fall reached 13.29% in 2022.
• Tracing MANH's EBITDA over 5 years: stood at $44.7 million in 2022, then jumped by 31.67% to $58.9 million in 2023, then rose by 3.1% to $60.7 million in 2024, then advanced by 10.42% to $67.0 million in 2025, then dropped by 3.1% to $64.9 million in 2026.
• Per Business Quant, the three latest MANH EBITDA figures stand at $64.9 million (Q1 2026), $67.0 million (Q4 2025), and $75.8 million (Q3 2025).

Peer Comparison